Latest Licensing News

Australian Rare Earths Limited (ASX, AR3) has acquired exploration license EL6895, adding 972 km² to its Overland Uranium Project and uncovering significant near-surface uranium potential from historic data. Drilling is set to resume in July 2025 to test this promising new target alongside existing deeper uranium prospects.

Artrya Limited has secured a five-year, US$0.6 million contract with Tanner Health, marking its inaugural commercial revenue in the U.S. market for its AI-powered Salix Coronary Anatomy platform.

Tivan Limited has visually confirmed copper mineralisation at two sites within its Turiscai Project in Timor-Leste, setting the stage for assay results later this year and resource drilling in 2026.

Perpetual Resources has intersected over 200 meters of continuous lithium-caesium-tantalum pegmatite at its Igrejinha Project in Brazil, revealing promising signs of strategic caesium mineralisation alongside lithium. Initial assay results are expected soon, with further drilling underway to expand the discovery.

DY6 Metals has addressed an ASX price query by confirming confidential negotiations for acquiring additional mining licenses in Cameroon, explaining recent share price movements and ensuring compliance with continuous disclosure rules.

Activeport Group Ltd has secured a landmark contract to deploy its advanced network orchestration software across Ishan Technologies’ vast Indian infrastructure, automating connectivity for over 12,000 edge devices and enhancing service delivery for 85,000 customers.

Zeus Resources has completed the acquisition of the Casablanca Antimony Project in Morocco, unlocking access to exceptionally high-grade antimony mineralisation and positioning itself in a mining-friendly jurisdiction.

MedAdvisor Limited has finalized the sale of its Australian and New Zealand operations to Jonas Software for an estimated $42.35 million, marking a strategic pivot towards its US business. The company also announced upcoming CFO changes as it refocuses its growth trajectory.

EVE Health Group has placed its first commercial purchase order for Dyspro™, a cannabinoid-based pharmaceutical targeting painful menstruation, signaling a key step toward market entry. The product is set for manufacturing and distribution within weeks, tapping into a rapidly growing global women’s health market.

Australian Mines Limited has secured earn-in rights to the advanced Boa Vista Gold Project in Brazil’s prolific Tapajós Gold Province, aiming to earn up to an 80% stake through staged exploration and development milestones. The company also announced a $2.5 million capital raising to fund upcoming exploration activities.

RPMGlobal reports a strong 30.9% rise in software sales for FY2025, driven by subscription growth, with recurring revenue and backlog reaching new highs.

Aumake Limited unveils a major FY26 restructuring, splitting operations into two focused units and targeting acquisitions in health supplements to boost profitability and market reach.